作者
Domenico Alvaro,Cesare Hassan,Vincenzo Cardinale,Guido Carpino,Luca Fabris,Enrico Gringeri,Vincenza Granata,Massimiliano Mutignani,Helen Morement,Felice Giuliante,Alfredo Guglielmi,Lorenzo Ridola,Marco Marzioni,Gian Luca Grazi,Maria Guido,Emilio Di Giulio,Giuseppe Tonini,Francesco Pantano,Rosanna Venere,Maria Consiglia Bragazzi,Francesca Biancanello,Jessica Faccioli,Aurora Giannetti,Marcello Cintolo,Michela Di Giunta,Martina Gambato,Alberto Lasagni,Francesco Izzo,Antonio Avallone,Jesús M. Bañales,Massimo Rossi,Carlo Catalano,Andrea Laghi,Giulia d’Amati,Maria Grazia Mancino,Lorenzo Ridola
摘要
Abstract
Cholangiocarcinoma (CCA) is the second most common primary liver cancer, characterized by a poor prognosis and resistance to chemotherapeutics. The progressive increase in CCA incidence and mortality registered worldwide in the last two decades and the need to clarify various aspects of clinical management have prompted the Italian Association for the Study of the Liver (AISF) to commission the drafting of dedicated guidelines in collaboration with a group of Italian scientific societies. These guidelines have been formulated in accordance with the Italian National Institute of Health indications and developed by following the GRADE method and related advancements.